# EDGAR Filing Document

**Accession Number:** 0001178697
**File Stem:** 0001493152-25-018637
**Filing Date:** 2025-10
**Character Count:** 65218
**Document Hash:** 4a87d3dfee8f294c3f01d2d9d219cead
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-018637.hdr.sgml**: 20251020

**ACCESSION NUMBER**: 0001493152-25-018637

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20251016

**ITEM INFORMATION**: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251020

**DATE AS OF CHANGE**: 20251020

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SONIM TECHNOLOGIES INC
- **CENTRAL INDEX KEY:** 0001178697
- **STANDARD INDUSTRIAL CLASSIFICATION:** TELEPHONE & TELEGRAPH APPARATUS [3661]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 943336783
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38907
- **FILM NUMBER:** 251403849

**BUSINESS ADDRESS:**
- **STREET 1:** 4445 EASTGATE MALL
- **STREET 2:** SUITE 200
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121
- **BUSINESS PHONE:** 650-378-8100

**MAIL ADDRESS:**
- **STREET 1:** 4445 EASTGATE MALL
- **STREET 2:** SUITE 200
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d)**

**of The Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported) **October 16, 2025**

**Sonim Technologies, Inc.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-38907** | **94-3336783** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

**4445 Eastgate Mall, Suite 200, San Diego, CA 92121**

(Address of principal executive offices, including Zip Code)

**(650) 378-8100**

(Registrant's telephone number, including area code)

**Not applicable.**

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each Class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.001 per share | SONM | The Nasdaq Stock Market LLC<br> (Nasdaq Capital Market) |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.**

As disclosed in the Current Report on Form 8-K of Sonim Technologies, Inc. (the "Company") filed with the Securities and Exchange Commission (the "SEC"), on August 22, 2025, the Company received a letter (the "Deficiency Letter") from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company's stockholders' equity, as reported in its Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the "Form 10-Q"), did not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1) for the Nasdaq Capital Market, which requires that a listed company's stockholders' equity be at least $2.5 million.

On October 6, 2025, the Company submitted to the Nasdaq staff a plan to regain compliance with Nasdaq Listing Rule 5550(b)(1).

On October 17, 2025, the Company received written notification from Nasdaq (the "Extension Notice") granting the Company an extension through December 31, 2025, to regain compliance with Nasdaq Listing Rule 5550(b)(1). Under the terms of the extension, on or before December 31, 2025, the Company must evidence compliance with Nasdaq Listing Rule 5550(b)(1) as set forth in the Extension Notice. The Company intends to satisfy these requirements within the current extension period or, if necessary, to request a further extension from Nasdaq, which would be subject to Nasdaq's discretion.

The Company is undertaking measures to regain compliance within the extension period; however, there can be no assurance that the Company will ultimately regain compliance with Nasdaq Listing Rule 5550(b)(1) or be able to maintain compliance with all other applicable requirements for continued listing on Nasdaq. The Company's failure to meet these requirements could result in the Company's securities being delisted from Nasdaq.

**Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

***Executive Chairman Appointment***

 ****

On October 16, 2025, the board of directors (the "Board") of the Company appointed Mr. Michael Mulica to serve as Executive Chairman of the Board effective as of October 16, 2025 (the "Effective Time").

Michael Mulica, age 62, has served as a member of the Board since April 2021 and Chairman of the Board since November 2023. Mr. Mulica has served as a Partner at Avataar Venture Partners since November 2019. Mr. Mulica has served on the board of Global Digital Holdings, conducting business as QumulusAI, an AI data center operator optimizing for enterprise-grade AI workloads, since September 2025. He has served as Chairman at AlefEdge, a global edge API platform company, since March 2018, and as its Chief Executive Officer from August 2021 to May 2024. From May 2018 to present, Mr. Mulica has served as the Global Management Advisor at Mulica Consulting, advising public and private companies on global mobile Internet and application platforms. From May 2016 to August 2018, Mr. Mulica served as Chief Executive Officer and President of Actility Technologies, Inc., an IoT communications and software company. From June 2014 to May 2016, Mr. Mulica served as the President, Worldwide Sales and Business Development at Real Networks, Inc., a content and Internet software company. From October 2011 to July 2014, Mr. Mulica served as the Chief Executive Officer and President of Openwave Systems, Inc., a mobile internet software company. Prior to his service at Openwave Systems, he held various leadership positions at Motorola, Inc., a communications systems company, Synchronoss Technologies, an Internet software and services company, FusionOne, Inc., a pioneer in the development of the Cloud, BridgePort Technologies, Inc., a pioneer in the development of fixed to mobile convergence, Phone.com, Inc., inventor of the mobile Internet, California Microwave, Inc., a microwave and satellite systems company, and Tandem Computers, a fault tolerant computer manufacturer. Mr. Mulica holds a BS in Finance from Marquette University and an MBA from the Kellogg School of Management at Northwestern University. The Board believes that Mr. Mulica's extensive operational, executive, and board experience with numerous private and public companies at various internet, mobile, and software companies, and his perspective on the Company's strategic alternatives, qualify him to serve as the Executive Chairman of the Board.

***Executive Chairman Employment Agreement***

In connection with Mr. Mulica's appointment as Executive Chairman, the Company and Mr. Mulica entered into an employment agreement, dated as of October 16, 2025 (the "Employment Agreement"), pursuant to which Mr. Mulica commenced service as the Company's Executive Chairman of the Board at the Effective Time.

The term of employment under the Employment Agreement is for one (1) year, and will automatically renew for successive one-year periods unless either party provides at least ninety (90) days' advance written notice of non-renewal.

For his service as Executive Chairman, the Company shall pay Mr. Mulica an annual base salary of $300,000 (the "Base Salary"). Mr. Mulica is also entitled to receive an annual grant of $250,000 in restricted stock units (the "Annual Grant") under the Sonim Technologies, Inc. 2019 Equity Incentive Plan (the "EIP"). The Annual Grant will vest in equal quarterly installments over a two-year period, with such installments vesting on each quarterly anniversary of the date of grant. Additionally, Mr. Mulica is also entitled to receive a grant of $500,000 in restricted stock units (the "Asset Purchase Award") under the EIP, vesting upon the consummation of that certain asset purchase agreement by and among the Company, Pace Car Acquisition LLC, the Seller Representative named therein, and Social Mobile Technology Holdings LLC.

If, at the grant date of any Annual Grant or the Asset Purchase Award, the amount of shares of the Company's outstanding common stock ("Common Stock") available under the EIP is not sufficient to issue the restricted stock units pursuant to the Employment Agreement, then, in lieu of the Annual Grant and the Asset Purchase Award, the Company shall issue a cash award (the "Substitute Cash Grant") to Mr. Mulica. The Substitute Cash Grant will be determined using the following methodology:

● Assuming that the number of restricted stock units valued as described in the terms of the respective grant has been granted as of the date of the grant (such assumed restricted stock units, the "Phantom RSUs");

● Assuming that the Phantom RSUs vest on the earlier of: (a) a change in control, as defined in the EIP, or any other event accelerating vesting of the respective award; or (b) a vesting event pursuant to the terms of the grant (each (a) and (b), a "Vesting Event"); and

● The Substitute Cash Grant shall equal the Fair Market Value (as defined in the EIP) of Common Stock underlying the Phantom RSUs at the time of the Vesting Event and shall be payable as of the date of the Vesting Event.

In addition to the aforementioned compensation received for service as the Executive Chairman, Mr. Mulica is also entitled to receive the same compensation as he would have been entitled to receive in his capacity as an independent chairman of the Board, including annual fees and restricted stock unit grants, pursuant to the Company's Non-Employee Director Compensation Policy.

On a termination of Mr. Mulica's service by the Company without "cause," upon a Change in Control, cessation of business, or due to the Company's election not to renew or extend the term of the Employment Agreement, or on a termination by Mr. Mulica for "good reason" (each as defined in the Employment Agreement), Mr. Mulica will be entitled to receive, subject to his execution and non-revocation of a general release of claims in favor of the Company, the following:

● the remaining Base Salary for the remaining portion of the employment term;

● one (1) year of Base Salary, to be paid over twelve (12) months in accordance with the Company's standard payroll practices;

● the Annual Grant, Asset Purchase Award, and any other awards under the EIP (or the Substitute Cash Grants, as and if applicable) will vest immediately upon termination; and

● any expense reimbursements for expenses accrued prior to the date of termination, for which submissions were made within thirty (30) days of such expense.

Mr. Mulica will be bound by standard restrictive covenants under the Employment Agreement, including, among other terms, confidentiality restrictions and assignment of intellectual property.

The foregoing description of the Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Employment Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

**Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.**

At a special meeting of the stockholders of the Company held on October 16, 2025 (the "Special Meeting"), the Company's stockholders approved the amendment to the Company's amended and restated certificate of incorporation (the "Certificate of Incorporation"), described in the Company's definitive proxy statement filed with the SEC on September 19, 2025, to increase in the number of authorized shares of Common Stock from 100,000,000 shares to 1,000,000,000 shares (the "Authorized Share Proposal").

On October 16, 2025, the Company effected the Authorized Share Proposal by filing a certificate of amendment to the Certificate of Incorporation (the "Certificate of Amendment") with the Secretary of State of the State of Delaware, effective as of such date.

The above description is qualified in its entirety by reference to the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

**Item 5.07. Submission of Matters to a Vote of Security Holders.**

The Special Meeting was held on October 16, 2025. Holders of 12,056,361 shares of the Company's common stock, or approximately 67.8% of the shares outstanding as of the record date, were represented at the meeting in person or by proxy, constituting a quorum. The following are the voting results on each matter submitted to the stockholders of the Company at the Special Meeting.

<u>Proposal 1</u>: The stockholders did approve an amendment to the Certificate of Incorporation to effect a reverse stock split of the Company's outstanding common stock by combining outstanding shares into a lesser number of shares at a ratio of not less than 1-for-2 and not greater than 1-for-30, with the exact ratio to be set within that range at the discretion of the Board. The results of the vote were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Votes For** | **Votes Against** | **Votes Abstained** | **Broker Non-Votes** |
| 10547566 | 1494782 | 14013 |  |

---

<u>Proposal 2</u>: The stockholders did approve an amendment to the Certificate of Incorporation to increase the number of authorized shares of the Company's common stock from 100,000,000 to 1,000,000,000. The results of the vote were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Votes For** | **Votes Against** | **Votes Abstained** | **Broker Non-Votes** |
| 8401652 | 3651408 | 3301 |  |

---

<u>Proposal 3</u>: The stockholders did not approve an amendment to the Sonim Technologies, Inc. 2019 Equity Incentive Plan, as amended, to increase the aggregate number of shares of common stock authorized for issuance by 1,000,000 shares (the "Plan Amendment"). The results of the vote were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Votes For** | **Votes Against** | **Votes Abstained** | **Broker Non-Votes** |
| 2330823 | 5556598 | 2030 | 4166910 |

---

<u>Proposal 4</u>: The stockholders did approve a proposal, permitting the Company to adjourn the Special Meeting one or more times, if necessary or appropriate, from time to time, to a later date or dates, even if a quorum is present, to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve the Reverse Stock Split Proposal, Authorized Share Proposal, and the Plan Amendment. The results of the vote were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Votes For** | **Votes Against** | **Votes Abstained** | **Broker Non-Votes** |
| 7802183 | 4153092 | 101086 |  |

---

**Item 8.01** **Other Events.**

 

*Reverse Stock Split*

On October 15, 2025, the Board approved a reverse stock split of Common Stock at a final ratio of 1-for-18 (one-for-eighteen) (the "Reverse Stock Split") subject to the stockholder approval of the Reverse Stock Split. The Reverse Stock Split is expected to become effective at 12:01 a.m. Eastern Time on October 27, 2025, following the filing of a certificate of amendment to the Certificate of Incorporation with the Secretary of State of the State of Delaware. The Common Stock is expected to commence trading on a split-adjusted basis when the markets open on October 27, 2025, under the existing trading symbol "SONM." The new CUSIP number for the Common Stock following the Reverse Stock Split will be 83548F 408. The primary goal of the Reverse Stock Split is to increase the per share market price of the Common Stock to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.

No fractional shares will be issued if, as a result of the Reverse Stock Split, a stockholder would otherwise become entitled to a fractional share because the number of shares of Common Stock they hold before the Reverse Stock Split is not evenly divisible by the Reverse Stock Split ratio. If, as a result of the Reverse Stock Split, a stockholder of record would otherwise hold a fractional share, such stockholder of record will be entitled to receive a cash payment in lieu of such fractional share equal to the fraction of which such stockholder of record would otherwise be entitled multiplied by the closing price per share of Common Stock as reported by the Nasdaq Capital Market (as adjusted to give effect to the Reverse Stock Split) on the date the certificate of amendment to the Certificate of Incorporation to effect the Reverse Stock Split is filed with the Secretary of State of the State of Delaware.

Equiniti Trust Company, LLC (formerly American Stock Transfer & Trust Company) is acting as the exchange agent and transfer agent for the Reverse Stock Split. Stockholders holding their shares electronically in book-entry form are not required to take any action to receive post-split shares. To its best knowledge, the Company does not have any outstanding certificated shares. Stockholders owning shares through a bank, broker, or other nominee will have their positions adjusted to reflect the Reverse Stock Split in accordance with their respective bank's, broker's, or nominee's particular processes. If applicable, a check representing a cash payment in lieu of fractional shares will also be mailed to a stockholder of record's registered address as soon as practicable after the effective time of the Reverse Stock Split.

*Forward-Looking Statements*

 

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this Current Report on Form 8-K that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, the timeline trading of the Common Stock on a split-adjusted basis and the ability of the Company to satisfy the listing requirements of Nasdaq. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "future," "believe," "expect," "may," "will," "intend," "estimate," "continue," or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. Factors that may cause actual results to differ materially include, but are not limited to, potential material delays in realizing projected timelines and risks related to the Company's ability to comply with the continued listing standards of Nasdaq and the potential delisting of the Common Stock. It is very difficult to predict the effect of known factors, and the Company cannot anticipate all factors that could affect actual results that may be important to an investor. All forward-looking information should be evaluated in the context of these risks, uncertainties, and other factors, including those factors disclosed in this Current Report and those factors disclosed under "Risk Factors" in the Company's most recent Annual Report on Form 10-K filed with the SEC and the Company's subsequent Quarterly Reports on Form 10-Q filed with the SEC. The Company cautions you not to place undue reliance on forward-looking statements, which speak only as of the date hereof. The Company assumes no obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this report, except as required by law.

**Item 9.01** **Financial Statements and Exhibits.** 

(d) Exhibits

---

| | |
|:---|:---|
| **Exhibit<br> Number** | **Description** |
| 3.1 | [Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Sonim Technologies, Inc. (increase in authorized shares from 100,000,000 to 1,000,000,000)](ex3-1.htm) |
| 10.1\* | [Employment Agreement, dated as of October 16, 2025, by and between the Company and Michael Mulica](ex10-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

\* Certain schedules and attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish a copy of such schedules and attachments to the SEC upon its request.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | SONIM TECHNOLOGIES, INC. | SONIM TECHNOLOGIES, INC. |
| Date: October 20, 2025 | By: | */s/ Clay Crolius* |
|  | Name: | Clay Crolius |
|  | Title: | Chief Financial Officer |

---

## Exhibit 3.1

**Exhibit 3.1**

**CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION**

**OF SONIM TECHNOLOGIES, INC.**

Sonim Technologies, Inc. (the "Corporation"), a corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. This Certificate of Amendment (the "Certificate of Amendment") amends the provisions of the Corporation's Amended and Restated Certificate of Incorporation, as amended to date, filed with the Secretary of State of the State of Delaware on May 14, 2019 (the "Amended and Restated Certificate of Incorporation").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Article IV, Paragraph A of the Amended and Restated Certificate of Incorporation is hereby amended and restated in its entirety as follows:

"A. This Company is authorized to issue two classes of stock to be designated, respectively, "***Common Stock***" and "***Preferred Stock***." The total number of shares which the Company is authorized to issue is 1,005,000,000 shares. 1,000,000,000 shares shall be Common Stock, having a par value per share of $0.001 and 5,000,000 shares shall be Preferred Stock, having a par value per share of $0.001."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. This amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. All other provisions of the Amended and Restated Certificate of Incorporation shall remain in full force and effect.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by Peter Liu, its Chief Executive Officer, this 16 day of October, 2025.

---

| | |
|:---|:---|
| By: | */s/ Peter Liu* |
| Name: | Peter Liu |
| Title: | Chief Executive Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**Sonim Technologies, Inc.**

**EMPLOYMENT AGREEMENT**

This employment agreement (the "Agreement"), effective as of October 16, 2025 (the "Effective Date"), by and between Sonim Technologies, Inc., a Delaware Corporation (the "Company") located at 4445 Eastgate Mall, Suite 200, San Diego, CA 92121, and Michael Mulica (the "Executive" and, together with the Company, the "Parties"), having address at [\*\*\*].

The Executive shall commence employment on the Effective Date.

**WHEREAS**, the Company desires to assure itself of the continued services of Executive by engaging Executive as an employee of the Company to perform services under the terms hereof; and

**WHEREAS**, Executive desires to provide continued services to the Company on the terms herein provided.

**NOW, THEREFORE**, in consideration of the foregoing, and for other good and valuable consideration, including the respective covenants and agreements set forth below, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:

1. <u>Performance of Duties</u>. The Executive agrees that during his employment, he shall make his first priority,
 and devote his primary attention, energies, and talents performing the duties, as set out
 in **Exhibit A** attached to this Agreement, assigned to him by the Company faithfully,
 efficiently, and in a professional manner (the "Duties"). The Executive shall
 report to the Board of Directors of Sonim Technologies, Inc. (the "Board"). During
 his employment, Executive may invest, consult, advise, and participate in other businesses
 in an advisory capacity and manage the Executive's personal investments and affairs,
 participate in non-profit, educational, industry, community, business or philanthropic activities,
 in each case, to the extent that such activities do not interfere with the performance of
 the Executive's Duties under this Agreement and are not in conflict with the business
 interests of the Company or otherwise compete with the Company. Furthermore, to the extent
 he may do so under his other signed confidentiality arrangements, the Executive agrees to
 promptly disclose to the Company all business opportunities that are presented to the Executive
 in his capacity as an officer or employee of the Company.

2. <u>Compensation</u>.
 Subject to the terms and conditions of this Agreement, the Executive shall be compensated
 by the Company for his services as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. <u>General Compensation Structure. Base Salary</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The Executive shall be entitled to receive the same compensation as he would have been entitled to receive in his capacity as the independent Chairman of the Board, including annual fees and RSU grants, pursuant to the Company's Non-Employee Director Compensation Policy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) For the additional executive role, the Company shall pay the Executive an annual rate base salary of $300,000 in periodic installments in accordance with the Company's customary payroll practices, but no less frequently than monthly (the "Base Salary").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B. <u>Equity Awards and Cash payments in lieu thereof</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Unconditional Annual RSU Award</u>. Commencing as of the Effective Date, the Executive, on an annual basis, shall be awarded (the "Annual Grant") a total of $250,000 in restricted stock units ("RSUs") under the Sonim Technologies, Inc. 2019 Equity Incentive Plan or any successor plan (the "EIP"), having a grant date Fair Market Value (as defined in the EIP) and vesting in equal quarterly installments over a two-year period, with such installments vesting on each quarterly anniversary of the date of grant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <u>Transaction Bonus</u>. Commencing as of the Effective Date, the Executive shall be awarded (the "Asset Purchase Award") a total of $500,000 RSUs under the EIP, having a grant date Fair Market Value (as defined in the EIP) and vesting upon the consummation of the asset purchase agreement by and among the Company, as seller, Pace Car Acquisition LLC, as buyer, the Seller Representative named in the Asset Purchase Agreement, and, Social Mobile Technology Holdings LLC (the "APA"). In the event the Asset Purchase Agreement is terminated, the Asset Purchase Award shall be deemed to be null and void *ab initio*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C. <u>Substitute Cash Grant</u>. In the event, at the grant date of any Annual Grant or the Asset Purchase
 Award, the amount of RSUs under the EIP is not sufficient to issue the RSUs pursuant to this
 Agreement, then, in lieu of the Annual Grant and the Asset Purchase Award, the Company shall
 issue a cash award (the "Substitute Cash Grant") to be determined using the following
 methodology:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Assume
 that the number of RSUs valued as described in the terms of the respective grant has been
 granted as of the date of the grant (such assumed RSUs, the "Phantom RSUs");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Assumption
 that the Phantom RSUs vest on the earlier of: (a) a change in control, as defined in the
 EIP, or any other event accelerating vesting of the respective award; or (b) a vesting event
 pursuant to the terms of the grant (each (a) and (b), a "Vesting Event");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) the
 Substitute Cash Grant shall equal the Fair Market Value of the Company's common stock
 underlying the Phantom RSUs at the time of the Vesting Event and shall be payable as of the
 date of the Vesting Event.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D. <u>Tax Obligation Sell rights</u>. At a vesting event, the Company shall hold back an amount of
 vested RSUs to satisfy the Executive's cash tax withholding requirement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;E. <u>Fringe Benefits and Perquisites</u>. During the employment term, the Executive shall be entitled
 to fringe benefits and perquisites consistent with the practices of the Company and to the
 same extent as other executives of the Company. The Company reserves the right to amend or
 cancel any fringe benefits or perquisites at any time in its sole discretion.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;F. <u>Expense Reimbursement</u>. The Executive shall be reimbursed by the Company for all reasonable out-of-pocket
 business, promotional, travel, and entertainment expenses incurred or paid by him during
 the performance of his services under this Agreement. The Executive agrees to adhere to the
 Company expense reimbursement policies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;G. <u>Employee Benefits</u>. The Executive shall be eligible to participate in the employee benefit plans,
 practices, and programs maintained by the Company, as in effect from time to time, and to
 the same extent as other executives of the Company. The Company reserves the right to amend
 or cancel an employee benefit plan, practice, or program at any time in its sole discretion,
 subject to the terms of such plan and applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Vacation/Personal Days</u>. The Executive will be entitled to four (4) weeks of paid vacation per calendar year (prorated for partial years), in accordance with the Company's vacation policies, as in effect from time to time. The Executive shall receive other paid time off and holidays, in accordance with the Company's policies for executive officers, as such policies may exist from time to time.

3. <u>Term and Termination</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. <u>Term</u>.
 Subject to earlier termination as hereafter provided, Executive's employment hereunder
 shall be for an initial term of one (1) year, commencing as of the Effective Date of this
 Agreement (the "Employment Term"), unless earlier terminated in accordance with
 Section 3(B). Following the expiration of the Employment Term, this Agreement shall be automatically
 renewed for successive one (1) year periods ("Renewal Term") unless, at least
 ninety (90) days prior to the expiration of the Employment Term or the then current Renewal
 Term, either Party provides the other with written notice of intention not to renew, in which
 case this Agreement shall terminate as of the end of the Employment Term or the Renewal Term,
 as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B. <u>Termination of Employment</u>. Notwithstanding anything to the contrary herein, the Executive's
 employment hereunder shall terminate prior to the expiration of the Term under the following
 circumstances:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Death</u>.
 The Executive's employment hereunder shall automatically terminate upon his death.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Total Disability</u>. The Company may terminate the Executive's employment upon the Executive
 becoming "Totally Disabled." For purposes of this Agreement, "Totally Disabled"
 means any physical or mental ailment or incapacity as determined by a licensed physician
 in good standing selected by the Company, which prevents or is reasonably expected to prevent
 the Executive from performing the Duties incident to the Executive's employment hereunder
 which has continued for a period of ninety (90) consecutive days or (B) one hundred twenty
 (120) total days in any twelve (12) month period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Termination by the Company for Cause</u>. The Company may terminate the Executive's employment
 hereunder for "Cause;" provided that Company provides written notice to Executive
 specifying in reasonable detail the circumstances claimed to provide the basis for such termination
 and an opportunity to appear before the Board of Directors within ten (10) days of receipt
 of such notice, provided however, that, if the Company reasonably expects irreparable injury
 from a delay of ten (10) days, the Company may give the Executive notice of such shorter
 period or terminate with immediate effect. For purposes of this Agreement, the term "Cause"
 means any of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Upon
 written notice in the event of any conviction or plea of guilty or nolo contendere with respect
 to any crime constituting a felony or other crime involving moral turpitude, whether or not
 in the course of the Executive's Duties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) The
 Executive's knowing and willful failure to comply with any laws, rules or regulations
 of any federal, state or local authority having jurisdiction over the Company and its business
 operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) The
 Executive's willful unauthorized disclosure of Confidential Information (as defined
 below);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) fraud,
 embezzlement, or misappropriation involving personal profit by the Executive.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Termination by the Company upon Cessation of Business</u>. The Company may terminate Executive's
 employment hereunder upon notice to the Executive, in the event the Company ceases conducting
 business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Termination by the Company without Cause</u>. The Company may decide to terminate the Executive's
 employment hereunder without Cause (*i.e.*, for any reason or no reason) at any time
 by providing ninety (90) days' written notice to the Executive. The Company reserves
 the right to pay the Executive's pro-rated Base Salary for the remaining amount of
 the Initial Term or the Renewal Term, as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <u>Voluntary Termination by the Executive</u>. The Executive may terminate his employment hereunder at
 any time by providing written notice to the Company at least ninety (90) days prior to his
 voluntary termination of employment, unless otherwise agreed to in writing by the Company,
 in which case such shorter period shall apply. The Company reserves the right to pay the
 Executive's base salary in lieu of all or part of the notice period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <u>Termination by the Executive for Good Reason</u>. The Executive may terminate his employment hereunder
 for Good Reason. For purposes of this Agreement, "Good Reason" shall mean the
 occurrence of any of the following, in each case, during the employment term without the
 Executive's written consent:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) a
 material reduction in the Executive's Base Salary, other than a general reduction in
 Base Salary that affects all similarly situated executives in substantially the same proportions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) any
 material breach by the Company of any material provision of the Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) a
 material, adverse change in the Executive's title, authority, duties, or responsibilities
 (other than temporarily while the Executive is physically or mentally incapacitated or as
 required by applicable law);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) the
 Company's failure to obtain an agreement from any successor to the Company to assume
 and agree to perform this Agreement in the same manner and to the same extent that the Company
 would be required to perform if no succession had taken place, except where such assumption
 occurs by operation of law.

The Executive cannot terminate his employment for Good Reason unless he has provided written notice to the Company of the existence of the circumstances providing grounds for termination for Good Reason within fifteen (15) days of the initial existence of such grounds and the Company has had at least fifteen (15) days from the date on which such notice is provided to cure such circumstances. If the Executive does not provide notice to the Company, as provided by this Section, or if the Executive does not terminate employment for Good Reason within fifteen (15) days of the expiration of the Company's cure period, then the Executive will be deemed to have waived his right to terminate for Good Reason with respect to such grounds.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <u>Termination by the Company upon Change in Control</u>. The Company may terminate Executive's employment
 hereunder upon notice to Executive, in the event there is a "change in control."
 For purposes of this Agreement, "Change in Control" means:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) as
 such term is defined in the EIP (as in effect on the date hereof),

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) during
 the period of two (2) consecutive years, individuals who, at the beginning of such period,
 constitute the Board together with any new director(s) (other than a director designated
 by a Person who has entered into an agreement with the Company to effect a transaction described
 in Section 13(i) of the Plan) whose election by the Board or nomination for election by the
 Company's stockholders was approved by a vote of at least two-thirds of the directors
 then still in office who either were directors at the beginning of the two (2) year period
 or whose election or nomination for election was previously so approved, cease for any reason
 to constitute a majority thereof; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) a
 complete liquidation or dissolution of the Company or the consummation of a sale or disposition
 by the Company of all or substantially all of the Company's assets other than the sale
 or disposition of all or substantially all of the assets of the Company to a Person or Persons
 who beneficially own, directly or indirectly, fifty percent (50%) or more of the combined
 voting power of the outstanding voting securities of the Company at the time of the sale.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Termination by mutual consent</u>. The parties may terminate this Agreement by mutual consent upon such terms as they may agree in writing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) <u>Notice of Termination</u>. Any termination by the Company or by the Executive under this Agreement shall be communicated by written notice to the other party.

4. <u>Obligations and Compensation Following Termination of Employment</u>. In the event that Executive's
 employment hereunder is terminated, Executive shall have the following obligations and be
 entitled to the following compensation and benefits upon such termination:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Termination by the Company without Cause, upon Cessation of Business, upon Change in Control, or by the Executive for Good Reason; non-renewal of the Initial Term</u>. In the event that the Executive's
 employment is (x) terminated during either the Initial Term or Renewal Term or not renewed
 during the Initial Term by the Company without Cause pursuant to Section 3(e) above or (y)
 terminated by the Company upon Cessation of Business pursuant to Section 3(d) above, upon
 Change in Control pursuant to Section 3(h) above, or (z) by the Executive for Good Reason
 pursuant to Section 3(g) above, the Company shall pay the following amounts to the Executive
 and nothing else, subject to the Executive's compliance with the provisions contained
 in this Agreement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the
 Executive's Base Salary for the remaining portion of the Employment Term or Renewal
 Term (as applicable), payable in accordance with the Company's regular payroll schedule,
 together with any unpaid amounts earned but not yet paid as of the termination or non-renewal
 date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) one
 (1) year of Base Salary to be paid over 12 months in accordance with the Company's
 standard payroll practice;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) all
 equity awards and the Substitute Cash Grant of the Executive shall vest immediately upon
 termination of the Initial Term or Renewal Term or non-renewal of the Initial Term, as applicable;
 and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) any
 expense reimbursements for expenses accrued prior to the date of termination, for which submissions
 were made within thirty (30) days of such expense.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Termination due to Death or by the Company for Disability</u>. In the event that the Executive's
 employment is terminated due to the Executive's death or by the Company as a result
 of the Executive being deemed to be Totally Disabled pursuant to Section 3(b) above, the
 Company shall pay to the Executive, to Executive's designated beneficiary or, if no
 beneficiary has been designated by Executive, to his estate, as applicable, pro-rated Base
 Salary for the remaining amount of the Initial Term or the Renewal Term, as applicable and
 nothing else. Additionally, all outstanding equity awards and the Substitute Cash Grant of
 the Executive shall vest immediately upon death or Total Disability, as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Termination by the Company for Cause or Voluntary Termination by Executive</u>. In the event that Executive's
 employment is terminated by the Company for Cause pursuant to Section 3(c) above, or by Executive's
 voluntary termination, the Company shall pay to the Executive any accrued but unpaid Salary
 for services rendered to the date of termination, any outstanding expense reimbursements,
 and nothing else. All outstanding unvested awards and the Substitute Cash Grant granted to
 the Executive shall be forfeited.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Executive's Obligation to Execute a General Release</u>. In the event that Executive's employment
 is terminated pursuant to Section 4(a), the Company's obligation to pay severance,
 as set forth in Section 4(a)(ii), and the acceleration and retention of unvested awards and
 the Substitute Cash Grant as set forth in Section 4(a)(iii), shall be conditioned upon the
 Executive executing within sixty (60) days after such termination of employment, and not
 revoking, a valid waiver and release of all claims that the Executive may have against the
 Company in a form reasonably satisfactory to the Company (which waiver and release of all
 claims shall not waive or release claims for amounts payable pursuant to this Agreement).
 Severance payments (including back payments) shall commence on the 60<sup>th</sup> day following
 termination of employment, assuming a waiver has been executed and become effective.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Cooperation</u>.
 The parties agree that certain matters in which the Executive will be involved may necessitate
 the Executive's cooperation in the future. Accordingly, following the termination of
 the Executive's employment for any reason, to the extent reasonably requested by the
 Company, the Executive agrees to cooperate with the Company in connection with matters arising
 out of his service to the Company; provided that, the Company shall make reasonable efforts
 to minimize disruption of the Executive's other activities. The Company shall reimburse
 the Executive for reasonable expenses incurred in connection with such cooperation and, to
 the extent that the Executive is required to spend substantial time on such matters, the
 Company shall compensate the Executive at an hourly rate based on the Executive's Salary
 on the Termination Date.

5. <u>Confidentiality and Restrictive Covenant Agreement</u>. The Executive acknowledges and agrees that his employment
 with the Company and any compensation and benefits provided for hereunder is subject to the
 Executive's execution of a Confidentiality and Restrictive Covenant Agreement with
 the Company, in the form attached hereto as **Exhibit B** (the "Confidentiality
 Agreement"). In connection therewith, the Executive acknowledges and agrees that the
 Company's obligations to make any payments or confer any benefit under this Agreement,
 other than to pay for all compensation and benefits accrued but unpaid up to the date of
 termination, will automatically and immediately terminate in the event that Executive breaches
 any provision of the Confidentiality Agreement; provided that the Company provides written
 notice to the Executive specifying in reasonable detail the circumstances claimed to provide
 the basis for such breach.

6. <u>Notices and Waivers</u>. Any notice or waiver to be given hereunder by a party hereto shall be in
 writing and shall be delivered by e-mail, personal delivery, by overnight courier, or first
 class registered or certified mail, postage prepaid, return receipt requested:

---

| | | |
|:---|:---|:---|
| 7. | If to the Company: | c/o Clay Crolius, CFO |
|  |  | 4445 Eastgate Mall, Suite 200, |
|  |  | San Diego, CA 92121 |
|  |  | E-mail: [\*\*\*] |

---

If to the Executive: Michael Mulica <br> [\*\*\*] <br> E-mail: [\*\*\*]

8. <u>Arbitration</u>.
 Any claim by any party for breach or enforcement of any provision of this Agreement or arising
 out of the Executive's employment with the Company, other than any claims for injunctive
 relief, will be subject to binding arbitration by the American Arbitration Association, pursuant
 to the rules of procedure in effect at the time any claim is made the parties' agreement
 to arbitrate includes statutory claims, including those arising under antidiscrimination
 laws. The venue for arbitration will be New York City, New York. The decision of the arbitrator
 shall be in writing and shall be final and conclusive, and the parties waive the right to
 a trial de novo or appeal, except only for the purpose of enforcing the arbitrator's
 decision. The arbitrator shall have the power to award any relief that would be available
 if the dispute had been brought in a court of competent jurisdiction. The prevailing party
 will be entitled to recover reasonable attorneys' fees and costs of bringing or defending
 the arbitration and any action for enforcement, the amount of the awards to be determined
 by the arbitrator and the Court, respectively.

9. <u>Indemnification</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) In
 the event that the Executive is made a party or threatened to be made a party to any action,
 suit, or proceeding, whether civil, criminal, administrative or investigative (a "Proceeding"),
 other than any Proceeding initiated by the Executive or the Company related to any contest
 or dispute between the Executive and the Company or any of its affiliates with respect to
 the Agreement or the Executive's employment hereunder, by reason of the fact that the
 Executive is or was a director or officer of the Company, or any affiliate of the Company,
 or is or was serving at the request of the Company as a director, officer, member, employee
 or agent of another corporation or a partnership, joint venture, trust or other enterprise,
 the Executive shall be indemnified and held harmless by the Company to the maximum extent
 permitted under applicable law and the Company's bylaws from and against any liabilities,
 costs, claims and expenses including all costs and expenses incurred in defense of any Proceeding
 (including attorneys' fees). In the event any liability arises on the Company as a
 direct or indirect result of any act by the Executive, which required an approval or authorization
 by the Board of Directors of the Company but which has not been approved or authorized by
 the Board of Directors, the Executive shall indemnify and hold harmless the Company and its
 directors, officers, employees or agents, from and against any and all third party actions,
 claims, expenses, judgments, liabilities, damages or losses to the maximum extent permitted
 under applicable law and the Company's bylaws. Costs and expenses incurred by the Executive
 or the Company (as the case maybe) in defense of such Proceeding (including attorneys'
 fees) shall be paid by the Company or the Executive (as the case maybe) in advance of the
 final disposition of such litigation upon receipt by the Company or the Executive (as the
 case maybe) of: (i) a written request for payment; (ii) appropriate documentation evidencing
 the incurrence, amount and nature of the costs and expenses for which payment is being sought;
 and (iii) an undertaking adequate under applicable law made to repay the amounts so paid
 if it shall ultimately be determined that the Executive or the Company (as the case may be)
 is not entitled to be indemnified by the Executive or the Company (as the case may be) under
 this Agreement. These obligations shall survive the termination of the Executive's
 employment with Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Clawback Provisions</u>. Notwithstanding any other provisions in this Agreement to the contrary, any
 incentive-based compensation, or any other compensation, paid to the Executive pursuant to
 this Agreement or any other agreement or arrangement with the Company which is subject to
 recovery under any law, government regulation or stock exchange listing requirement, will
 be subject to such deductions and claw back as may be required to be made pursuant to law,
 government regulation or stock exchange listing requirement (or any policy adopted by the
 Company pursuant to any such law, government regulation or stock exchange listing requirement).

10. <u>Section 409A Compliance</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 intent of the parties is that payments and benefits under this Agreement comply with, or
 be exempt from, Internal Revenue Code ("Code") Section 409A and, accordingly,
 to the maximum extent permitted, this Agreement shall be interpreted to be in compliance
 therewith. In no event whatsoever shall the Company be liable for any additional tax, interest
 or penalty that may be imposed on Executive by Code Section 409A or any damages for failing
 to comply with Code Section 409A.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any
 payments to be made under this Agreement in connection with a termination of employment shall
 only be made if such termination of employment constitutes a "separation from service"
 under Code Section 409A.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) To
 the extent any reimbursement of costs or expenses provided for herein constitutes taxable
 income to the Executive for Federal income tax purposes, all such reimbursements shall be
 made no later than December 31st of the calendar year next following the calendar year in
 which the expenses to be reimbursed are incurred.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) With
 regard to any provision herein that provides for reimbursement of expenses or in-kind benefits,
 except as permitted by Code Section 409A, (x) the right to reimbursement or in-kind benefits
 is not subject to liquidation or exchange for another benefit, and (y) the amount of expenses
 eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not
 affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any
 other taxable year, provided that the foregoing clause (y) shall not be violated with regard
 to expenses reimbursed under any arrangement covered by Section 105(b) of the Code solely
 because such expenses are subject to a limit related to the period the arrangement is in
 effect.

For purposes of Code Section 409A, Executive's right to receive any installment payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments. Whenever a payment under this Agreement specifies a payment period with reference to a number of days, the actual date of payment within the specified period shall be within the sole discretion of the Company.

11. <u>Modification</u>.
 In the event any provision of this Agreement is determined to be invalid or unenforceable
 for any reason, such provision shall be deemed modified, if possible, to the extent required
 to render it valid, enforceable, and binding, and such determination shall not affect the
 validity or enforceability of any other provision of this Agreement.

12. <u>Successors and Assigns</u>. This Agreement is personal to the Executive and shall not be assigned by
 the Executive. Any purported assignment by the Executive shall be null and void. The Company
 may assign this Agreement to any successor or assign (either direct or indirect, by purchase,
 merger, consolidation or otherwise) to all or substantially all of the business or assets
 of the Company. This Agreement shall inure to the benefit of the Company and permitted successors
 and assigns.

13. <u>Counterparts</u>.
 This Agreement may be executed in multiple counterparts, each such counterpart being deemed
 an original copy thereof.

14. <u>Amendment and Waiver</u>. Failure by either party at any time to enforce any of the terms hereof or
 a breach by the other party shall not constitute a waiver of any of the provisions hereof
 or of subsequent breaches. The parties may, by mutual written consent, make changes to this
 Agreement.

15. <u>Entire Agreement</u>. This Agreement and the Confidentiality Agreement constitute the entire and
 final expression of the agreement between the parties pertaining to the subject matter hereof,
 and supersede all prior related communications or agreements, whether oral, written, or electronically
 transmitted, between the parties.

16. <u>Governing Law, Jurisdiction and Venue</u>. This Agreement shall be construed in accordance with the
 laws of New York without regard to conflicts of law principles. Subject to Section 8 of this
 Agreement, any action or proceeding by either of the parties to enforce this Agreement shall
 be brought only in a state or federal court located in the state of New York. The parties
 hereby irrevocably submit to the jurisdiction of such courts.

17. <u>Acknowledgment of Full Understanding</u>. THE EXECUTIVE ACKNOWLEDGES AND AGREES THAT HE HAS FULLY READ,
 UNDERSTANDS AND VOLUNTARILY ENTERS INTO THIS AGREEMENT. THE EXECUTIVE ACKNOWLEDGES AND AGREES
 THAT HE HAS HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY OF HIS CHOICE
 BEFORE SIGNING THIS AGREEMENT.

18. <u>Survival</u>.
 It is expressly agreed between the parties that, notwithstanding anything contained herein
 to the contrary, the provisions of Sections 4, 5, 6, 7, 8, 9, 10, 11, 16, and 18 of this
 Agreement shall survive any termination under this Agreement and shall remain and continue
 in full force and effect.

\* \* \* \* \*

[signature page to follow]

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first written above.

---

| | |
|:---|:---|
| **COMPANY:** | **COMPANY:** |
| **SONIM TECHNOLOGIES, INC.** | **SONIM TECHNOLOGIES, INC.** |
| By: | */s/ Peter Liu* |
| Name: | Peter Liu |
| Title: | Chief Executive Officer |

---

---

| |
|:---|
| **EXECUTIVE:** |
| */s/ Michael Mulica* |
| Michael Mulica |

---

*[Signature Page to Employment Agreement]*

**Exhibit A**

**Duties and Responsibilities of the Executive**

The Executive Chairman is responsible to the shareholders and reports to the board. The Executive Chairman is an employee of the Company and has daily duties. The Executive Chairman functions both as an executive, meaning they report to the CEO, and they are also responsible for leading the Board of Directors.

As part of his mandates, the Executive Chairman:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) will
 be in charge of the management of the Company in partnership with the CEO, with responsibilities,
 duties, and authority usual and customary for such positions, subject to direction by the
 Board;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shall
 report directly to the Board; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) agrees
 promptly and faithfully to comply with all present and future policies, requirements, rules
 and regulations, and reasonable directions and requests, of the Company in connection with
 the Company's business.

At the Company's request, Executive shall serve the Company and/or its subsidiaries and affiliates in such other capacities in addition to the foregoing as the Company shall designate, provided that such additional capacities are consistent with Executive's position as the Company's Executive Chairman. In the event that Executive serves in any one or more of such additional capacities, Executive's compensation shall not automatically be increased on account of such additional service.

**Exhibit B**

Confidentiality Agreement